TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31066715

Group type: EXPERIMENTAL
Intervention: Mixed recruitment approach (including opportunistic methods, social media, and local organizations)
Number of subjects: 10691

Group type: EXPERIMENTAL
Intervention: Facebook and mailing lists
Number of subjects: 10691

Group type: EXPERIMENTAL
Intervention: Direct street recruitment
Number of subjects: 10691

Group type: COMPARATOR
Intervention: Random sampling in Örebro
Number of subjects: 10691
Study: 30146493

Group type: EXPERIMENTAL
Intervention: External expert consultation model (workshop, therapy manual, expert follow-up consultation)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Train-the-trainer model (staff member coached to train others)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: External expert consultation model
Number of subjects: 26

Group type: COMPARATOR
Intervention: Train-the-trainer model
Number of subjects: 26
Study: 28186934

Group type: EXPERIMENTAL
Intervention: 8-week mindfulness course
Number of subjects: 550

Group type: COMPARATOR
Intervention: Mental health provision as usual
Number of subjects: 550
Study: 25187423

Group type: EXPERIMENTAL
Intervention: 9-week moderate-intensity physical activity intervention
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control group (no physical activity intervention)
Number of subjects: 271
Study: 22919767

Group type: EXPERIMENTAL
Intervention: Internet-based patient education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Face-to-face education with a nurse
Number of subjects: 0
Study: 19605623

Group type: EXPERIMENTAL
Intervention: Web-based surveys
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paper surveys
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed-mode surveys
Number of subjects: 0
Study: 17230050

Group type: EXPERIMENTAL
Intervention: Cue exposure therapy (CET)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo psychotherapy treatment (PPT)
Number of subjects: 127
Study: 15302737

Group type: EXPERIMENTAL
Intervention: Fondaparinux (2.5 mg once daily)
Number of subjects: 5385

Group type: COMPARATOR
Intervention: Enoxaparin (approved regimens)
Number of subjects: 5385
Study: 11245762

Group type: EXPERIMENTAL
Intervention: Aided wheelies (AW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional wheelies (CW)
Number of subjects: 42
Study: 10225047

Group type: EXPERIMENTAL
Intervention: 3 week course of 70 degrees head-up tilt for 30 min daily (Group-I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Specific yogic exercises equivalent to head-up or head-down tilt for 30 min daily (Group-II)
Number of subjects: 20
Study: 7870559

Group type: EXPERIMENTAL
Intervention: Relaxation training (5 sessions of 1.5 hours each)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Exercise reduction (to no more than 5 hours of aerobic activity per week)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (maintained current exercise regimen)
Number of subjects: 57
Study: 3367001

Group type: EXPERIMENTAL
Intervention: Variable rate pacing (VVIR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Single rate demand pacing (VVI)
Number of subjects: 16
Study: 30461319

Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release (ECTR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Open carpal tunnel release (OCTR)
Number of subjects: 30
Study: 29020191

Group type: EXPERIMENTAL
Intervention: TST/QFT arm
Number of subjects: 871

Group type: COMPARATOR
Intervention: TST arm
Number of subjects: 871
Study: 27027501

Group type: EXPERIMENTAL
Intervention: SRP + AMX + MET (500 mg × 3 times daily for 3 days)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: SRP + AMX + MET (500 mg × 3 times daily for 7 days)
Number of subjects: 102

Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 102
Study: 25209620

Group type: EXPERIMENTAL
Intervention: Integrated disease management intervention delivered by trained general practitioners, practice nurses, and specialised physiotherapists.
Number of subjects: 1086

Group type: EXPERIMENTAL
Intervention: Integrated disease management intervention
Number of subjects: 1086

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1086
Study: 23535525

Group type: EXPERIMENTAL
Intervention: ABBS±ACE‐I (Aspirin, Beta-blockers, Statins, with/without Angiotensin-converting enzyme inhibitor) (n=513)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Aspirin (A)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Beta-blockers (BB)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Statins (S)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme inhibitor (ACE-I)
Number of subjects: 819
Study: 20883265

Group type: EXPERIMENTAL
Intervention: Mesotherapy administration of meglumine antimoniate
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional injection of meglumine antimoniate
Number of subjects: 85
Study: 17941902

Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel (LAN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Octreotide long-acting repeatable (OCT)
Number of subjects: 12
Study: 16622372

Group type: EXPERIMENTAL
Intervention: Combined one-stage anterior stabilization with mesh cage and SSTF (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Solely SSTF with intermediate screws in the fractured vertebra (Group B)
Number of subjects: 40
Study: 12622937

Group type: EXPERIMENTAL
Intervention: Meropenem 500 mg every 12 hours (or 1 g every 12 hours if necessary)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Imipenem/cilastatin 500 mg/500 mg every 12 hours (or 1 g every 12 hours if necessary)
Number of subjects: 182
Study: 10626827

Group type: EXPERIMENTAL
Intervention: Acetate-free biofiltration (AFB) with AN69 membrane and bicarbonate solution infusion (NaHCO3 145 or 167 mEq/lt)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Bicarbonate hemodialysis (BD)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both AFB and BD
Number of subjects: 400
Study: 7491551

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate, 750 micrograms/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate, 1500 micrograms/day
Number of subjects: 21
Study: 1838460

Group type: EXPERIMENTAL
Intervention: History of back injury claim
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Shorter duration of employment
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Recent job change
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: History of non‐back injury claim
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Overtime and being female among heavy lifters
Number of subjects: 228
Study: 6452802

Group type: EXPERIMENTAL
Intervention: Amitriptyline 75 mg nocte (increasing to 150 mg nocte)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zimelidine 100 mg nocte (increasing to 200 mg nocte)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 12
Study: 31969173

Group type: EXPERIMENTAL
Intervention: Low-dose inhaled nitric oxide (5-10 ppm)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 134
Study: 30589351

Group type: EXPERIMENTAL
Intervention: Treatment integrity procedures
Number of subjects: 270
Study: 25644360

Group type: EXPERIMENTAL
Intervention: 1-min modified sham feeding (MSF) with 100 kcal gastric load
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 1-min modified sham feeding (MSF) with 700 kcal gastric load
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 8-min modified sham feeding (MSF) with 100 kcal gastric load
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 8-min modified sham feeding (MSF) with 700 kcal gastric load
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no MSF, 500 mL of water)
Number of subjects: 26
Study: 23831385

Group type: EXPERIMENTAL
Intervention: Combined resistance training and aerobic training
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 83
Study: 21508886

Group type: EXPERIMENTAL
Intervention: Cervical total disc replacement (TDR‐C)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 187
Study: 19523094

Group type: EXPERIMENTAL
Intervention: Gum chewing (one stick of sugarless gum for 15 minutes every 2 hours after surgery)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional management (oral intake of clear fluids allowed after passage of flatus and regular diet with the passage of bowel movement)
Number of subjects: 200
Study: 17135064

Group type: EXPERIMENTAL
Intervention: Hypnosis (standardized, individual 8‐session hypnosis treatment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 15210926

Group type: EXPERIMENTAL
Intervention: Extraction group
Number of subjects: 83

Group type: COMPARATOR
Intervention: Non-extraction group
Number of subjects: 83
Study: 11466161

Group type: EXPERIMENTAL
Intervention: Controlled-release lovastatin 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled-release lovastatin 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled-release lovastatin 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled-release lovastatin 60 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10460956

Group type: EXPERIMENTAL
Intervention: Educational program of 2 hours duration implemented twice a year
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Educational program plus a 0.12% chlorhexidine rinse weekly
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Educational program, chlorhexidine rinse, and fluoride varnish application twice a year
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: All interventions including scaling and root planing every 6 months
Number of subjects: 297

Group type: COMPARATOR
Intervention: Usual care from a public health department or a private practitioner
Number of subjects: 297
Study: 7821093

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 20
Study: 2369034

Group type: EXPERIMENTAL
Intervention: Hydrophilic contact lenses worn full time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spectacles worn as age-matched controls
Number of subjects: 0
Study: 290649

Group type: EXPERIMENTAL
Intervention: Stannous fluoride compounds
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo compounds
Number of subjects: 37
Study: 30360960

Group type: EXPERIMENTAL
Intervention: AlaGln (8 mM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28101516

Group type: EXPERIMENTAL
Intervention: Postocclusive time to peak flow measured by laser Doppler flowmetry
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Baseline microvascular blood flow
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transcutaneous oxygen tension
Number of subjects: 100
Study: 23815270

Group type: EXPERIMENTAL
Intervention: Functioning assessment based on the International Classification of Functioning, Disability and Health (ICF)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional medical assessment
Number of subjects: 81
Study: 23161049

Group type: EXPERIMENTAL
Intervention: Piezoelectric surgery (PS Group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Conventional rotary osteotomy technique (RT Group)
Number of subjects: 12
Study: 20025830

Group type: EXPERIMENTAL
Intervention: Peanut supplementation (about 77 g) with habitual diet for 4 weeks
Number of subjects: 54
Study: 18367384

Group type: EXPERIMENTAL
Intervention: APTD (acute phenylalanine/tyrosine depletion)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: APTD + L-DOPA
Number of subjects: 16

Group type: COMPARATOR
Intervention: BAL (nutritionally balanced amino acid mixture)
Number of subjects: 16
Study: 15866255

Group type: EXPERIMENTAL
Intervention: Group detailing (N=227 prescribers)
Number of subjects: 9820

Group type: EXPERIMENTAL
Intervention: Individual detailing (N=235 prescribers)
Number of subjects: 9820

Group type: COMPARATOR
Intervention: Usual care (N=319 prescribers)
Number of subjects: 9820
Study: 14599264

Group type: EXPERIMENTAL
Intervention: Single target (cocaine only)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Dual target (cocaine and heroin)
Number of subjects: 58
Study: 10645328

Group type: EXPERIMENTAL
Intervention: Low serum total cholesterol
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 29133
Study: 8863150

Group type: EXPERIMENTAL
Intervention: Children and patients with severe diseases
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Aged individuals, patients with mild diseases, and patients with self-acquired diseases
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Poor or rich patients
Number of subjects: 295
Study: 1353933

Group type: EXPERIMENTAL
Intervention: 10 mg ridazolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 20 mg ridazolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 40 mg ridazolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 80 mg ridazolol
Number of subjects: 15
Study: 6355394

Group type: EXPERIMENTAL
Intervention: Relaxation therapy with spouse
Number of subjects: 31

Group type: COMPARATOR
Intervention: Relaxation therapy alone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Relaxation therapy (both groups)
Number of subjects: 31
Study: 2858664

Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 109

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 109
Study: 28573820

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control
Number of subjects: 135
Study: 27455036

Group type: EXPERIMENTAL
Intervention: HYPO (mild hypohydration)
Number of subjects: 25
Study: 24732289

Group type: EXPERIMENTAL
Intervention: Sutezolid 600 mg BID
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Sutezolid 1200 mg QD
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard 4-drug therapy
Number of subjects: 59
Study: 23193905

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol‐remifentanil hydrochloride (PR)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Inhalational anesthesia with sevoflurane‐remifentanil hydrochloride (SR)
Number of subjects: 23
Study: 20014162

Group type: EXPERIMENTAL
Intervention: Allergic Rhinitis Nose Drops (ARND)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 18577834

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 15793649

Group type: EXPERIMENTAL
Intervention: Topical 0.2 percent glyceryl trinitrate paste, applied to the lower anal canal, three times daily for eight weeks.
Number of subjects: 27

Group type: COMPARATOR
Intervention: Water-soluble lubricating jelly applied to the lower anal canal.
Number of subjects: 27
Study: 12781350

Group type: EXPERIMENTAL
Intervention: Active nonparticipant 'manic' and passive nonparticipant 'sad' roles (abnormal social behaviour)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Active participant 'warm' and passive participant 'shy' roles (normal social behaviour)
Number of subjects: 63
Study: 11310906

Group type: EXPERIMENTAL
Intervention: Propofol EDTA
Number of subjects: 39

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 39
Study: 8867904

Group type: EXPERIMENTAL
Intervention: Gliclazide, 160 mg/24 h
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (in association with standard insulin treatment)
Number of subjects: 22
Study: 1346491

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition plus somatostatin (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total parenteral nutrition alone (group A)
Number of subjects: 40
Study: 6378491

Group type: EXPERIMENTAL
Intervention: Frusemide (40 mg for 3 days) with high salt intake (Na+ intake 270 mmol/day)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Frusemide (40 mg for 3 days) with low salt intake (Na+ intake 20 mmol/day)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Frusemide (40 mg for 3 days) with high salt intake plus captopril (25 mg/6 h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Water load during high salt intake followed by frusemide
Number of subjects: 6
Study: 29985820

Group type: EXPERIMENTAL
Intervention: Tailored lifestyle management program (TLMP) for 12 weeks, home-based after discharge.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Regular health education during hospitalization (Control group).
Number of subjects: 35
Study: 29985113

Group type: EXPERIMENTAL
Intervention: Electronic cigarette with nicotine-containing liquid
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Conventional cigarette
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nicotine-free liquid (Control)
Number of subjects: 15
Study: 27078992

Group type: EXPERIMENTAL
Intervention: Modified Guipi Decoction (MGD)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 245
Study: 24581773

Group type: EXPERIMENTAL
Intervention: Small-spot scanning laser (Allegretto Wave Eye‐Q system)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Variable-spot scanning laser (Visx Star Customvue S4 IR system)
Number of subjects: 100
Study: 21680809

Group type: EXPERIMENTAL
Intervention: Daily sildenafil (50 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 17876699

Group type: EXPERIMENTAL
Intervention: Intimate partner violence (IPV)
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Receptive syringe sharing (RSS)
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Self-esteem and depression as mediators
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Interventions focused on self-esteem and depression
Number of subjects: 797
Study: 17439902

Group type: EXPERIMENTAL
Intervention: IFNbeta treatment
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Any relapse during treatment
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Higher baseline EDSS score
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Failure of IFNbeta to completely suppress relapses
Number of subjects: 175
Study: 15711996

Group type: EXPERIMENTAL
Intervention: six-sample algorithm (preoperative, pre-excision, 5, 10, 20 and 60 min)
Number of subjects: 102

Group type: COMPARATOR
Intervention: two-sample algorithm (preoperatively and 10 min) with additional measurement at 20 min if needed
Number of subjects: 102
Study: 12468916

Group type: EXPERIMENTAL
Intervention: Mega-dose methylprednisolone therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 48
Study: 10424370

Group type: EXPERIMENTAL
Intervention: i.v. taprostene
Number of subjects: 366

Group type: COMPARATOR
Intervention: i.v. placebo
Number of subjects: 366
Study: 8887169

Group type: EXPERIMENTAL
Intervention: GHRP-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GHRH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GHRP-2 + GHRH
Number of subjects: 0
Study: 1997878

Group type: EXPERIMENTAL
Intervention: Sinemet CR (controlled release carbidopa/levodopa)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional carbidopa/levodopa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sinemet CR
Number of subjects: 0
Study: 6394243

Group type: EXPERIMENTAL
Intervention: Clomiphene
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study: 31365800

Group type: EXPERIMENTAL
Intervention: Transfusion of 30 ml per kilogram
Number of subjects: 3196

Group type: COMPARATOR
Intervention: Transfusion of 20 ml per kilogram
Number of subjects: 3196
Study: 29764447

Group type: EXPERIMENTAL
Intervention: Intra-articular hypertonic dextrose prolotherapy (DPT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 76
Study: 26758026

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) training focused on the forward modeling of purposive actions, delivered through instruction videos, 9 sessions of 45 min each over 9 weeks.
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cognitive Orientation to daily Occupational Performance (CO-OP) training focused on identifying effective cognitive strategies to increase motor competence, 9 sessions of 45 min each over 9 weeks.
Number of subjects: 2
Study: 26049830

Group type: EXPERIMENTAL
Intervention: Hydrophobic group (Y‐60H 3‐piece hydrophobic IOL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydrophilic group (MI60 1‐piece hydrophilic IOL)
Number of subjects: 60
Study: 23966446

Group type: EXPERIMENTAL
Intervention: 30% heart rate reserve
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 50% heart rate reserve
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 80% heart rate reserve
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 19965584

Group type: EXPERIMENTAL
Intervention: 1.7 g DHA plus 0.6 g EPA
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 18182992

Group type: EXPERIMENTAL
Intervention: Lower-dose ghrelin (2 microg kg(‐1))
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Upper-dose ghrelin (8 microg kg(‐1))
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 17259127

Group type: EXPERIMENTAL
Intervention: Epi-CH (activated charcoal-epirubicin suspension)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (aqueous epirubicin injection)
Number of subjects: 60
Study: 14652097

Group type: EXPERIMENTAL
Intervention: Single TMS during facilitation (controlateral hand grip and elbow flexion)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Paired TMS at rest
Number of subjects: 56

Group type: COMPARATOR
Intervention: Single TMS during facilitation
Number of subjects: 56
Study: 16948204

Group type: EXPERIMENTAL
Intervention: Non-invasive positive pressure ventilation (NPPV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NPPV
Number of subjects: 0
Study: 9172969

Group type: EXPERIMENTAL
Intervention: tianeptine 37.5 mg/day
Number of subjects: 286

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: tianeptine
Number of subjects: 286